STRATEGY FOR 16th MAY 2024
EQUITY
MARKET TREND - NIFTY(SPOT) - Positive (from 19720), stop - 21600.
BANKNIFTY(SPOT) - Positive(from 47700), stop - 46100.
INSTITUTIONAL ACTIVITY- Fii - Net sell - 2832 crores.
Dii - Net buy- 3788 crores.
GLOBAL MARKETS- US markets trading positive at the time of writing.
RESULTS TODAY - Biocon, Concor, Endurance, Gail, Hal, Infibeam, Naukri, M&m.
RESULTS TOMORROW - Amber, Astral, Balkrisind, Balrampurchini, Bandhan, Glaxopharma, Godrejind, Jbchem, Jswsteel, Nhpc, Pfizer, Polymed, Rvnl, Rcf, Sobha, Varroc, Vinatiorganics, Zeel, Zyduslife.
INVESTMENT IDEAS
Genus power - 67, booked half - 181. Philipcarb(10/01/2022) - 244,
Ajantpharma(18/04/2022) - 1740, Zyduswellness- 1630,
Ircon- 16/08/2022)- 41 - 03/05/2023) booked half- 84,
SOTL(14/12/2022)- 332, Texrail(14/12/2022)- 58, booked half- 145. Sail-(09/01/2022)- 88,
Niftybees - (22/03/2023)-188. Bel(08/08/2023)- 128.4, target hit- 200(booked half, rest for long
term). Canarabank - (11/09/2023) - 350, RPSG ventures (12/09/2023) - 655,
TVSSCS - (10/10/2023) - 211, Lincoln pharma (10/11/2023) - 555.
Muhurt picks- (12/11/2023)- Indramedco - 193, Itdcem- 229, Nile - 841.
DCMSRIND - (28/11/2023) - 167, Deepind(07/12/2023) - 271.50, Intellect -(26/12/2023)- 816,
SATINDLTD (04/01/2024) - 123.5, Rpglife(11/01/2024) - 1408, target - 1900, Sunteck(15/01/2024) - 459,
NAM-INDIA - 534 (30/01/2024), Polymed(01/02/2024) - 1500, Rkforge(12/02/2024)- 714, target - 1000,
JUPITER WAGONS(JWL) - 391 (19/02/2024), Alpa labs- 106(21/02/2024), PENIND - 134 (28/03/2024),
Natcopharma - 974 (01/04/2024), Gabriel (29/04/2024)- 374, Elecon(14/05/2024)- 1049,
Concor(14/05/2024) - 1025.
MEDIUM TERM
Morepenlab - Buy(12/02/2024) - 53, target - 68, stop hit( not exited yet) - 41.
MUTUAL FUNDS
Quant large & midcap fund (28/12/2023) - nav - 97.34, Mofsl large cap fund- NFO,
Nippon multicap fund- 251.
SHORT TERM
POSITIONAL
MAPMYINDIA - Buy (14/05/2024) - 2025, target - 2230, stop - 1875.
SUDARSCHEM - Buy (14/05/2024) - 742, target - 810, stop - 690.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home